Magnetic resonance imaging contrast agents synthesized using ring-opening metathesis polymerization
申请人:Wisconsin Alumni Research Foundation
公开号:US07807140B2
公开(公告)日:2010-10-05
Polymeric chelating agents and metal chelates, particularly those of lanthanide metals and more specifically those of Gd(III), useful as contrast agents in magnetic resonance imaging (MRI) for therapeutic and diagnostic applications as well as clinical and biomedical research applications. The polymeric chelates are generated using ring-opening metathesis polymerization (ROMP). Polymers can have multiple sites for functionalization allowing for the synthesis of multimodal and targeted contrast agents. Hydroxypyridonate (HOPO)-based chelating moieties are integrated into a ROMP-derived polymer. More specifically, the HOPO-based chelating moiety is integrated into a benzonorbornadiene unit that constitutes the backbone of the polymer. The ROMP-derived polymer chelators can comprise multiple metal ions, particularly Gd(III) ions, in polymers of varying lengths to provide a series of agents with controlled relaxivites. Polymer chelates include those that are water-soluble.
聚合螯合剂和金属螯合物,特别是稀土金属的螯合物,更具体地说是Gd(III)的螯合物,在磁共振成像(MRI)中作为对比剂用于治疗和诊断应用以及临床和生物医学研究应用。聚合螯合物是使用环状开环重合聚合(ROMP)生成的。聚合物可以具有多个功能化位点,允许合成多模式和靶向对比剂。羟基吡啶酮(HOPO)基螯合基团被整合到ROMP衍生聚合物中。更具体地说,HOPO基螯合基团被整合到构成聚合物骨架的苯并[2,3]环庚二烯单元中。ROMP衍生的聚合物螯合剂可以包含多种金属离子,特别是Gd(III)离子,以控制弛豫效果提供一系列对比剂。聚合物螯合物包括水溶性的。